Melanotan-1, also known in literature as Melanotan I or afamelanotide, is a linear alpha-MSH analogue
GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
Call the Right Weight Center to get started by scheduling a consultation
Much of the research framing treats it as an orally administered compound, and in practitioner circles it circulates in oral/sublingual forms (capsules, or the reconstituted solution taken sublingually)
Rising Prevalence of Type 2 Diabetes Globally Consumption of highly processed food containing refined sugars and unhealthy fats is causing more people to develop type 2 diabetes
10.1016/j.prp.2018.12.013 99 TanS.LiR.DingK.LobieP